Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: nitroglycerin

« Back to Dashboard

Nitroglycerin is the generic ingredient in fifteen branded drugs marketed by Mist Pharms Llc, Pohl Boskamp, Medicis, Valeant Pharm North, Merck Sharp Dohme, Hercon Pharm, Kremers Urban Pharms, Mylan Technologies, Novartis, Sanofi Aventis Us, Abraxis Pharm, Hospira, Intl Medication, Luitpold, Smith And Nephew, Baxter Hlthcare, Rorer, Parke Davis, Forest Labs Inc, Fougera, Perrigo Israel, and Pfizer Pharms, and is included in fourty NDAs. There are four patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are thirty-seven drug master file entries for nitroglycerin. Eighteen suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: nitroglycerin

Tradenames:15
Patents:4
Applicants:22
NDAs:40
Drug Master File Entries: see list37
Suppliers: see list18
Therapeutic Class:Cardiovascular Agents

Pharmacology for Ingredient: nitroglycerin

Ingredient-typeNitrates
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation

Tentative approvals for NITROGLYCERIN

Applicant Application No. Form Dosage
<disabled><disabled>Film, Extended Release; Transdermal0.2MG/HR
<disabled><disabled>Film, Extended Release; Transdermal0.4MG/HR
<disabled><disabled>Film, Extended Release; Transdermal0.6MG/HR

Clinical Trials for: nitroglycerin

Nitroglycerin in Non-small Cell Lung Cancer
Status: Recruiting Condition: Non Small Cell Lung Cancer (NSCLC)

Radial Artery Dilation Study: The Effect of Topical Administration of Nitroglycerin and Lidocaine Versus Lidocaine Alone of the Radial Artery Diameter
Status: Completed Condition: Healthy

Treatment of Suspected Cholelithiasis With Nitroglycerin
Status: Not yet recruiting Condition: COLIC; BILIARY TRACT DISEASES

MQX-503 vs Nitroglycerin Ointment: A Pharmacokinetic Comparison in Normal Subjects
Status: Completed Condition: Healthy

The Effect of Nitroglycerin on the Intrauterine Device (IUD) Insertion Experience in Nulliparous Women
Status: Recruiting Condition: Contraception; Pain

GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary Therapy
Status: Recruiting Condition: Prostate Cancer

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm
NITROGLYCERIN
nitroglycerin
INJECTABLE;INJECTION071203May 8, 1987DISCNNo<disabled><disabled>
Parke Davis
NITROSTAT
nitroglycerin
INJECTABLE;INJECTION018588Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Perrigo Israel
NITROGLYCERIN
nitroglycerin
SPRAY, METERED;SUBLINGUAL091496Sep 20, 2013RXNo<disabled><disabled>
Pohl Boskamp
NITROLINGUAL PUMPSPRAY
nitroglycerin
SPRAY, METERED;SUBLINGUAL018705Jan 10, 1997RXYes7,872,049<disabled>Y<disabled>
Smith And Nephew
NITROGLYCERIN
nitroglycerin
INJECTABLE;INJECTION070634Jun 19, 1986DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc